Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

Abroad (travel likely)RecruitingPHASE2

Conditions

LOCALLY ADVANCED CERVICAL CANCERS

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Cancer Center/Cancer Hospital, Beijing, China
Contact: Study coordinator (Iparomlimab/Tuvonralimab injection plus CCRT in LACC) · cancergcp@163.com · 010-67781331

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Advanced Solid Tumor · Advanced Malignant Neoplasm · Metastatic Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Irvine, United States · La Jolla, United States

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Solid Tumor Cancer · Locally Advanced · Metastatic Solid Tumors

Abroad (travel likely)RecruitingPHASE1, PHASE2

Gilbert, United States · Los Angeles, United States

Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Cervical Cancer

Abroad (travel likely)RecruitingPHASE2

Mexico City, Mexico

Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors

Breast Cancer · Ovarian Cancer · Endometrial Cancer

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States · Houston, United States